

Wiz Air Plunges, Wise's US Listing, Bayer Gains
Jun 5, 2025
Wizz Air's stock took a nosedive, plunging 26% after disappointing earnings and a lack of guidance. Meanwhile, Wise aims to list its shares in the US, signaling trouble for London's market. Bayer saw a notable boost of 5.1% after Goldman Sachs upgraded its stock, believing that earnings have hit bottom and that litigation risks are overstated. The discussion reveals the dynamic nature of the stock market, highlighting both challenges and opportunities.
AI Snips
Chapters
Transcript
Episode notes
Wizz Air's Severe Stock Drop
- Wizz Air shares dropped 27% due to earnings miss and uncertainty from the Eastern Europe conflict.
- High staffing and maintenance costs, plus supply issues with Airbus jets, heavily impacted performance.
Wise Plans US Listing Shift
- Wise plans to move its primary listing from London to the US for likely higher valuation.
- This move reflects a trend where UK-based companies seek better market pricing in US capital markets.
Bayer Share Boost from Legal Outlook
- Bayer's stock rose over 5% after Goldman Sachs upgraded it to buy.
- Goldman believes legal risks related to Roundup litigation are overblown, anticipating positive impact if Supreme Court reviews the case.